TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Zakwalifikowany przez zespół specjalistów szpitala jako dobry kandydat do leczenia metadonem lub buprenorfiną
✗ Disqualifies
- •Planowany wypis do domu opieki
- •Aktualnie przebywający w więzieniu, areszcie lub innej placówce zamkniętej wymagane prawnie
- •Oczekujące postępowanie sądowe z wysokim ryzykiem więzienia lub wymuszonym leczeniem zamkniętym
- •Niemożność wykazania zrozumienia procedur badania podczas procesu zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 21, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University of Cincinnati Addiction Sciences Division
Cincinnati, United States
Trial contact
Lindsay Bybee, MS
Ben Kropp Kropp, MSLS
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.